Brendan T. Heiden
Papers
1
Total Citations
28
H-Index
1
About
Brendan T. Heiden is a surgical outcomes researcher whose work focuses on the intersection of thoracic oncology, health economics, and minimally invasive surgery. His major contributions lie in evaluating the cost-effectiveness and clinical value of robotic-assisted techniques for lung cancer treatment, particularly lobectomy for non-small cell lung cancer. In his most-cited study, a 2021 cost-effectiveness analysis, Heiden demonstrated that robotic-assisted lobectomy can be a viable economic option when compared to traditional video-assisted thoracoscopic surgery, providing crucial data for healthcare decision-makers and surgeons. With over 28 citations on this key paper alone, his research has shaped discussions on balancing surgical innovation with financial sustainability. Heiden’s work is notable for its rigorous modeling and real-world applicability, helping to guide policy and practice in an era of rising healthcare costs. His findings are essential reading for students and clinicians interested in the value-based implementation of advanced surgical technologies in oncology.
Research Focus
Key Achievements
Top Papers
- 1